We use our own and third party cookies to offer you our services, customize and analyze your browsing and show you advertising related to your preferences. By continuing to browse, we consider that you accept its use. You can change the settings and get more information in the

  • jump to the main content
  • jump to the bottom of the page
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Search
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Assistance and health
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
    • Assistive Devices
    • Organizational structure
  • Research
    • Home
    • About research
    • Research areas
    • Core Facilities
    • Work at Idibaps
  • Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • Patients and companions
  • About the Clinic
  • News
  • Podcasts
  • Activities
  • Location and contact
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
COLLABORATE El Meu Clínic . This link opens in a new tab.
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
Navigation thread
  • Home
  • Organizational structure
  • The Biomedical Diagnostic Center
  • Immunology Service
  • News
  • Immunology Service

Service News from Immunology

Clínic Barcelona
Clínic Barcelona
December 21 2022 2022-12-22

Francisco Lozano appointed President of the Catalan Society of Immunology

The Members’ General Meeting, held to coincide with the Society’s 16th Congress which took place on 24 and 25 November, approved the appointment.

Clínic Barcelona
Clínic Barcelona
September 22 2022 2022-09-22

Carl H. June “In the next 10 years we will overcome the obstacles to treating solid tumors with CAR-T cells”

The University of Pennsylvania professor and pioneer in developing cancer therapies using T cells covered the history, current state, and future chal1

Clínic Barcelona
Clínic Barcelona
December 17 2021 2022-02-15

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1

Clínic Barcelona
Clínic Barcelona
July 1 2021 2021-07-16

Dr. Manel Juan:" “There are no good vaccines or bad vaccines”

Interview with Dr. Manel Juan, head of the Immunology Service

Clínic Barcelona
Clínic Barcelona
February 10 2021 2021-03-08

AEMPS authorises Hospital Clínic's CAR-T ARI-0001 for patients with acute lymphoblastic leukaemia

The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug o1

Clínic Barcelona
Clínic Barcelona
October 30 2020 2020-11-02

Can you be protected against COVID-19 without antibodies?

In just a few months, the coronavirus has gone from being completely unknown to being the focus of countless scientific investigations around the wor1

Clínic Barcelona
Clínic Barcelona
October 13 2020 2020-10-13

Immuneel Therapeutics, Hospital Clínic de Barcelona & IDIBAPS Announce a Strategic collaboration & a License Agreement

Immuneel Therapeutics Private Limited (Immuneel) today announced that it has entered into a multi-asset collaboration and licensing agreement with Ho1

Clínic Barcelona
Clínic Barcelona
June 10 2020 2020-06-11

A consortium of European hospitals led by Clínic IDIBAPS is launching a cellular immunotherapy project to tackle COVID-19 with the support of Cellnex Telecom

Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1

Clínic Barcelona
Clínic Barcelona
May 26 2020 2020-05-26

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1

Clínic Barcelona
Clínic Barcelona
July 5 2019 2019-12-11

Evolution of cancer immunotherapy: from bone marrow transplant to CAR

The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining th1

Subscribe to the Newsletter of Clínic

Receive the latest news from our institution directly to your email.

Thanks for your subscription!

We have received your information. Check your inbox, in a few moments you will receive a confirmation email.

An error has occurred and we have not been able to send your data, please try again later.
  • Assistance and health
    Assistance and health
    • Diseases, symptoms and health conditions
    • Tests and procedures
    • Be healthy
    • Urgencies
    • Patients and companions
  • Research
    Research
    • Home
    • About research
    • Research areas
    • Core Facilities
  • Teaching
    Teaching
    • Teaching
    • Students
    • Residents
    • Training stays
    • Training for professionals
  • Cookies policy
  • Profile of the contracting party
  • Legal Notice
  • Data protection
  • Transparency portal
  • Privacy policy
  • Español Contenido en español
  • Català Contingut en català
  • English Current language Spanish
© Clínic Barcelona 2023